Literature DB >> 1337005

Evidence for the prevention of oxidative tissue damage in the inner eye by vitamins E and C.

A J Augustin1, W Breipohl, T Böker, A Wegener.   

Abstract

The injection of oxidative metabolites such as lipid peroxides (LPO) into the vitreous cavity led to tissue damage demonstrable by a dose-dependent increase in intravitreal and intralental LPO levels, which are expressed as thiobarbituric-acid-reactive substances (TBARS). This process was accompanied by an inflammatory response as indicated by the occurrence of leukocyte-derived myeloperoxidase (MPO) in the vitreous body. Intramuscular injections of vitamin E were very effective in reducing both TBARS and MPO activity, whereas vitamin C had a moderate effect on TBARS only. The injection of a combination of the two vitamins was no more effective than treatment with vitamin E alone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1337005

Source DB:  PubMed          Journal:  Ger J Ophthalmol        ISSN: 0941-2921


  4 in total

Review 1.  Vitamin supplementation therapy in the elderly.

Authors:  J E Thurman; A D Mooradian
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

2.  Local effects of different perfluorochemical agents.

Authors:  A J Augustin; M Spitznas; F H Koch; T Böker; J Lutz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-01       Impact factor: 3.117

3.  Increased lipid peroxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy.

Authors:  A J Augustin; W Breipohl; T Böker; J Lutz; M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-11       Impact factor: 3.117

4.  Increased lipid peroxide level and myeloperoxidase activity in the vitreous of patients suffering from proliferative vitreoretinopathy.

Authors:  T Böker; A J Augustin; W Breipohl; M Spitznas; J Lutz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-11       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.